EUVIMEDEUVIMED entdecken
VergleichsstudieMetaanalyseSystematische ÜbersichtOpen Access · CC BY-NC-ND 4.0

A systematic review and meta-analysis of mortality in chronic Chagas cardiomyopathy versus other cardiomyopathies: higher risk or fiction?

Sergio A Gómez-Ochoa, Angie Yarlady Serrano-García, Alexandra Hurtado-Ortiz, Andrea Aceros, Lyda Z Rojas, Luis E Echeverría

Revista Española de Cardiología (English Edition) · 2024-10 · 77 (10) · 843-850

DOI: 10.1016/j.rec.2024.02.014 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Revista Española de Cardiología (English Edition), 2024-10. Verfasst von Sergio A Gómez-Ochoa und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clínica de Falla Cardiaca y Trasplante Cardiaco, Fundación Cardiovascular de Colombia, Floridablanca, Colombia; Department of General Internal Medici…. Hauptthemen laut MEDLINE: Cardiomyopathies, Chagas Cardiomyopathy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION AND OBJECTIVES: Although multiple studies suggest that chronic Chagas cardiomyopathy (CCC) has higher mortality than other cardiomyopathies, the absence of meta-analyses supporting this perspective limits the possibility of generating robust conclusions. The aim of this study was to systematically evaluate the current evidence on mortality risk in CCC compared with that of other cardiomyopathies. METHODS: PubMed/Medline and EMBASE were searched for studies comparing mortality risk between patients with CCC and those with other cardiomyopathies, including in the latter nonischemic cardiomyopathy (NICM), ischemic cardiomyopathy, and non-Chagas cardiomyopathy (nonCC). A random-effects meta-analysis was performed to combine the effects of the evaluated studies. RESULTS: A total of 37 studies evaluating 17 949 patients were included. Patients with CCC had a significantly higher mortality risk compared with patients with NICM (HR, 2.04; 95%CI, 1.60-2.60; I2, 47%; 8 studies) and non-CC (HR, 2.26; 95%CI, 1.65-3.10; I2, 71%; 11 studies), while no significant association was observed compared with patients with ischemic cardiomyopathy (HR, 1.72; 95%CI, 0.80-3.66; I2, 69%; 4 studies) in the adjusted-measures meta-analysis. CONCLUSIONS: Patients with CCC have an almost 2-fold increased mortality risk compared with individuals with heart failure secondary to other etiologies. This finding highlights the need for effective public policies and targeted research initiatives to optimally address the challenges of CCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CardiomyopathiesChagas CardiomyopathyHumansChronic DiseaseGlobal HealthRisk AssessmentRisk FactorsSurvival Rate

Stichwörter der Autor:innen

Chagas cardiomyopathyChagas diseaseEnfermedad de ChagasHeart failureInsuficiencia cardiacaMiocardiopatía chagásicaMortalidadMortality

Autor:innen und Institutionen

  • Clínica de Falla Cardiaca y Trasplante Cardiaco, Fundación Cardiovascular de Colombia, Floridablanca, Colombia; Department of General Internal Medicine and Psychosomatics, Heidelberg University Hospital, Heidelberg, Ger…
  • Clínica de Falla Cardiaca y Trasplante Cardiaco, Fundación Cardiovascular de Colombia, Floridablanca, Colombia.
  • Unidad de Epidemiología, Fundación Cardiovascular de Colombia, Floridablanca, Colombia.
  • Departamento de Administración en Salud, Fundación Cardiovascular de Colombia, Floridablanca, Colombia.
  • Grupo de Investigación y Desarrollo de Conocimiento en Enfermería (GIDCEN-FCV), Research Center, Fundación Cardiovascular de Colombia, Floridablanca, Colombia.

Zitieren

APA

Gómez-Ochoa, S. A., Serrano-García, A. Y., Hurtado-Ortiz, A., Aceros, A., Rojas, L. Z., & Echeverría, L. E. (2024). A systematic review and meta-analysis of mortality in chronic Chagas cardiomyopathy versus other cardiomyopathies: higher risk or fiction?. Revista Española de Cardiología (English Edition), 77(10), 843-850. https://doi.org/10.1016/j.rec.2024.02.014

Vancouver

Gómez-Ochoa SA, Serrano-García AY, Hurtado-Ortiz A, Aceros A, Rojas LZ, Echeverría LE. A systematic review and meta-analysis of mortality in chronic Chagas cardiomyopathy versus other cardiomyopathies: higher risk or fiction?. Revista Española de Cardiología (English Edition). 2024;77(10):843-850. doi:10.1016/j.rec.2024.02.014

BibTeX
@article{GmezOchoa2024,
  author = {Gómez-Ochoa, Sergio A and Serrano-García, Angie Yarlady and Hurtado-Ortiz, Alexandra and Aceros, Andrea and Rojas, Lyda Z and Echeverría, Luis E},
  title = {A systematic review and meta-analysis of mortality in chronic Chagas cardiomyopathy versus other cardiomyopathies: higher risk or fiction?},
  journal = {Revista Española de Cardiología (English Edition)},
  year = {2024},
  volume = {77},
  number = {10},
  pages = {843--850},
  doi = {10.1016/j.rec.2024.02.014}
}
Kostenlos starten →